Observations on new variant detected in Africa (Omicron)
-Many countries have closed borders, but I haven't heard of any that are simultaneously sending 10M vaccine doses to Africa.
-Closing borders while R>1 locally is silly. Virus is likely already widespread at v low freq.
-w/ no data, it's a bit shocking to see reputable people promoting 1 doctor's anecdotal observations that Omicron causes mild illness. If claim was opposite the same (always optimistic) scientist would demand to see data & suggest we don't believe it w/out rigorous analyses.
-interesting to see strong knee jerk reactions from reputable scientists (i.e. calling Omicron a scariant that we shouldn't worry about), while others take sequence data & mapping to make initial assessment that is worrisome:

-lots of folks pre-judging studies underway of neutralizing antibodies as not very valuable, despite strong data linking neutralizing antibodies to efficacy of vaccines (doi.org/10.1038/s41591…; medrxiv.org/content/10.110…)
-Some countries requiring 1 PCR test (sometimes post-arrival!) as if this will somehow stop introductions. It might reduce it a bit, but 1 test will miss many introductions. Only full 10d+ quarantine plus tests on day 10 will block most importations. @bencowling88
Here's what we know so far:
-Rise in cases in S Africa following subsiding of Delta wave ().
-New variant detected (Omicron B.1.1.529) coincident w/ rise w/ many mutations of concern inc. mutations that increase infectiousness ()
-Many Omicron mutations reduce antibody neutralization ()
-Many Omicron mutations have unknown effects
What we don't know:
-Transmissibility of Omicron relative to Delta & contributions of infectiousness & immune escape (anyone seen data supporting higher prob of reinfection? who.int/news/item/26-1…)
-Differences in severity of illness
Since we don't have hard data on 3 things we want to know about new variants: transmissibility, immune escape, disease severity. What should we do?
-local precautionary approach: try to prevent establishment which requires reducing R/transmission via vaccines, masks, distancing &
reduce importation. Since variant is likely already widespread blocking travel from a few countries is ineffective. Need widespread quarantine & testing.
-global precautionary approach: immediately deploy vaccines in hardest hit areas (Africa)
-medium term adaptation approach: develop vaccine booster specific to this variant; likely underway

-long term approach: deploy vaccines globally to reduce transmission & probability of future variants arising
Example of ineffective approach discussed above (ban travel, when variant is already clearly locally established & Rt>1):


epiforecasts.io/covid/posts/na…
Evidence omicron is already widespread (please don't try to argue we are detecting and stopping all introductions)

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with A Marm Kilpatrick

A Marm Kilpatrick Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DiseaseEcology

24 Nov
How do we get broad immunity to SARS-CoV-2 that will protect against future variants?
2 studies (are there more?) suggest that vaccination followed by infection gives broader protection than infection followed by vaccination.
@florian_krammer @profshanecrotty @GuptaR_lab
1st paper (medrxiv.org/content/10.110…) shows: if you get vaccinated w/ mRNA vaccine & have a breakthrough Delta infection your subsequent antibodies are almost equally reactive in neutralizing Delta, Beta, Alpha, WT.
2nd paper (science.org/doi/10.1126/sc…) shows if you get infected (probably w/ D614G) then vaccinated w/ mRNA vaccine, your immunity is strong vs D614G & Delta but less so vs the most immune evasive variant so far, Beta.
Read 6 tweets
27 Oct
Should we all get a vaccine booster (3rd dose)?
New preprint w @billy_gardner_ , we examine impact of 3rd doses on key topic: transmission.
medrxiv.org/content/10.110…
tl;dr 3rd dose could significantly reduce Rt & stop some surges, but doses should 1st go to unvaccinated if possible
Background
COVID-19 vaccines are fantastic. Better than we could have imagined. mRNA vaccines had efficacy of ~95% for symptomatic disease & even better for severe disease & death. But there's now strong evidence that protection against mild disease & infection is waning a bit.
Here's one study from the UK (there are many others) showing a reduction for Pfizer &Astrazeneca.
doi.org/10.1101/2021.0…
Read 26 tweets
10 Sep
What is driving current peaks in SARS-CoV-2 cases & what does this mean for the fall & winter?
Although a peak might seem to indicate that we're headed for fewer cases until a new variant arises, unfortunately that's not the case & a surge is both likely & avoidable.
A thread.
One possibility is in nice thread @trvrb suggesting US Delta surge is peaking now b/c 5% more of US pop infected, driving Rt down to 1 (which occurs at peak).
However, as @trvrb notes in addendum (), Rt at peak is 1 b/c of combination of behavior (which drives R0) and fraction susceptible (Rt = R0*S/N).
Read 16 tweets
15 Jun
Nice thread @EdMHill describing modeling from 1 of 3 teams on possible outcomes in UK that guided recent decision to postpone re-opening.
Big takeaways:
-I wish US gov had been open to scientific guidance in 2020
-Big uncertainty in behavior changes w/ re-opening
cont.
-Big uncertainty in relative transmissibility of delta (b.1.617.2) variant & vaccine effectiveness for transmission (not symptomatic disease). PHE-UK has provided fantastic real-time analyses of available data, but some critical data, that could be collected, are missing.
-Importance of limited vaccine supply. US can't seem to give away vaccine even with beer, lotteries & more. In UK (& most, but not all, of world) every dose is precious & in-demand.
Read 4 tweets
26 May
Why hasn't B.1.1.7 fully displaced other variants in US? What other variants are persisting/growing?
Thread
B.1.1.7 has risen to relatively high frequencies in many states, but hasn't exceeded 90% in any of them & may be falling in several.
Data here from @my_helix
GISAID sequences via fantastic outbreak.info for US as a whole suggest B.1.1.7 now stable @70%, P.1 is growing, B.1.526 frequencies are stable. But variable sequencing means finer resolution is better for understanding frequency dynamics, spatial variability & nuance.
Statewide scale is still too large but better than whole US.
Here's FL. Similar pattern as whole US - P.1 growing & B.1.526 stable, leading to slight recent decrease in B.1.1.7
Read 9 tweets
26 May
Yesterday I posted the tweet below as a joke.
Today I found so much bullshit (@callin_bull) it blows my mind.
Exhibit 1: The press release itself: investors.modernatx.com/news-releases/…
Yup, they claim 0 vs 4 cases = 100% efficacy.
Exhibit 2: NBC, USA today both parrot 100% efficacy claim.
Exhibit 3: Moderna CEO claims vaccine prevents infection (see quote). Note: there was no data presented from study on efficacy against infection (despite that being #1 reason to vaccinate kids). Only symptomatic disease (4 cases total), antibody response, & side effects.
It's worth noting that efficacy wasn't a primary endpoint of this trial - translation: the study wasn't trying to measure efficacy so there's no need for Moderna CEO to spout bullshit. Where is NIH partner telling them to cut the BS?
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Thank you for your support!

Follow Us on Twitter!

:(